Enablex
- Product NDC
- 0430-0170
- 11-digit product format
- 004300170
- Labeler code
- 0430
- Product ID
- 0430-0170_86b61495-b29e-46c4-9b40-491f35b4b8bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- darifenacin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Allergan, Inc.
- Application
- NDA021513
- Marketing category
- NDA
- Marketing start
- 2004-12-22
- Marketing end
- 2021-05-31
- Substance
- DARIFENACIN HYDROBROMIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0430-0170-00 | 00430017000 | 337500 TABLET, EXTENDED RELEASE in 1 DRUM (0430-0170-00) | | 2004-12-22 | 2021-05-31 | No | No | Current |
| 0430-0170-15 | 00430017015 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0430-0170-15) | | 2004-12-22 | 2021-05-31 | No | No | Current |
| 0430-0170-23 | 00430017023 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0430-0170-23) | | 2004-12-22 | 2021-05-31 | No | No | Current |
| 0430-0170-96 | 00430017096 | 1 BOTTLE in 1 CARTON (0430-0170-96) > 7 TABLET, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2004-12-22 | 2021-05-31 | No | No | Current |